About Us

Who are we

Medicines New Zealand is the industry association representing companies engaged in the research, development, manufacture and marketing of prescription medicines.

Membership of Medicines New Zealand is voluntary. The governing body of Medicines New Zealand is its Board of Directors which consists of an Independent Chair and eight members elected annually in March from the chief executive officers of member companies.

 

The Vision

Innovative medicines are recognised as leading health interventions that New Zealanders have access to when they need them.

Our core values

Ethical

We take a responsible approach and use evidence based arguments.

Accountable

We are cognisant of our responsibility to our members and to New Zealanders.

Collaborative

We recognise the fiscal pressures of providing health services and offer solutions before criticism.

Our people

Graeme Jarvis

General Manager
DDI: +64 27 499 1159

Monica Franklin

Board Secretary/Office Manager
DDI: +64 4 499 4277

Aaron Vinnell

Communications Advisor
DDI: +64 27 534 6461

Phyllida Duncan

Science and Technical Advisor
DDI: +64 27 894 4276

Board of directors

Heather Roy

Non-executive Chair

Alan Carter

Vice Chairman, Country Manager, Sanofi

Anna Stove

General Manager, GlaxoSmithKline

Michael Broome

Chief Executive, Healthcare Logistics

Paul Smith

Managing Director, Merck Sharp and Dohme

Tony Davison

Business Unit Manager New Zealand, Boehringer Ingelheim

Andrew Tompkin

Country Manager, AbbVie

Karen Saunders

Country Manager, Janssen Pharmaceutical

Tim Jones

Country Group Manager, Novartis

Daniel Thurley

Managing Director, Roche Products New Zealand